← All trials
NCT05004129
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 23, 2021
- Primary completion
- Mar 28, 2023
- Completion date
- Mar 28, 2023
- First posted
- Aug 13, 2021
- Last posted
- Nov 16, 2021
- Enrollment
- 56
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- AMO Pharma LimitedLead sponsor
- AMO Pharma LimitedStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.